Nordion Announces Completion of Acquisition by Sterigenics International
August 06 2014 - 1:56PM
Business Wire
Nordion Inc. (TSX:NDN) (NYSE:NDZ), a leading provider of
products and services to the global health science market,
announced today the successful completion of the previously
announced plan of arrangement (the “Arrangement”) and all of
the outstanding common shares of Nordion have been acquired by an
affiliate of Sterigenics International LLC (“Sterigenics”).
Pursuant to the Arrangement, the former holders of Nordion common
shares will receive US$13.00 in cash in exchange for each common
share held.
“We are extremely excited to welcome the Nordion employees onto
the Sterigenics global team,” said Michael Mulhern, CEO of
Sterigenics. “We believe this acquisition is transformative in
expanding our product and service offerings, broadening our global
footprint and allowing us to better serve customers worldwide.
Moving forward, Sterigenics is extremely well positioned to build
on its mission of improving global public health.”
It is anticipated that the Nordion common shares will be
delisted from the Toronto Stock Exchange and from the New York
Stock Exchange on or about August 7, 2014.
A registered shareholder must complete and send a letter of
transmittal with the certificate(s) representing its common shares
to CST Trust Company (the “Depositary”). The Depositary will
mail a cheque to the registered shareholder by first class mail as
soon as practicable after receipt of the completed letter of
transmittal and common share certificate(s). A copy of the letter
of transmittal is available under Nordion’s profile on SEDAR at
www.sedar.com and on EDGAR at www.sec.gov/edgar.
A non-registered shareholder will receive payment through its
account with the broker, investment dealer, bank, trust company or
other intermediary that holds common shares on its behalf. A
non-registered shareholder should contact its intermediary if it
has any questions about this process.
About Nordion Inc.
Nordion Inc. (TSX:NDN) (NYSE:NDZ) is a global health science
company that provides market-leading products used for the
prevention, diagnosis and treatment of disease. We are a leading
provider of medical isotopes and sterilization technologies that
benefit the lives of millions of people in more than 40 countries
around the world. Our products are used daily by pharmaceutical and
biotechnology companies, medical-device manufacturers, hospitals,
clinics and research laboratories. Nordion has over 400 highly
skilled employees in three locations. Find out more at
www.nordion.com and follow us at twitter.com/NordionInc.
Caution Concerning Forward-Looking Statements
This release contains forward-looking statements, within the
meaning of certain securities laws, including under applicable
Canadian securities laws and the “safe harbour” provisions of the
United States Private Securities Litigation Reform Act of 1995.
These forward-looking statements include, but are not limited to,
statements relating to our expectations with respect to our
beliefs, plans, objectives, expectations, anticipations, estimates
and intentions. The words “may”, “will”, “could”, “should”,
“would”, “outlook”, “believe”, “plan”, “anticipate”, “estimate”,
“project”, “expect”, “intend”, “indicate”, “forecast”, “objective”,
“optimistic”, and similar words and expressions are also intended
to identify forward-looking statements. Accordingly, readers should
not place undue reliance on the forward-looking statements and
information contained in this news release.
Since forward-looking statements and information address future
events and conditions, by their very nature they involve inherent
risks and uncertainties. Actual results could differ materially
from those currently anticipated due to a number of factors and
risks. Additional information on factors that could affect actual
results are included in reports on file with applicable securities
regulatory authorities, including in our 2013 Annual Information
Form (AIF) and our 2014 Management Information Circular. Our 2013
AIF, 2014 Management Information Circular, and our other filings
with the Canadian provincial securities commissions and the US
Securities and Exchange Commission are available on SEDAR at
www.sedar.com, on EDGAR at www.sec.gov, and on Nordion’s website at
www.nordion.com.
The forward-looking statements contained in this news release
are made as of the date of this release and, accordingly, are
subject to change after such date. The Company does not assume any
obligation to update or revise any forward-looking statements,
whether written or oral, that may be made from time to time by us
or on our behalf, except as required by applicable law.
NordionMEDIA & INVESTORS:Shelley Maclean,
613-592-3400 ext. 2414Shelley.Maclean@nordion.com
Nordion Inc. (NYSE:NDZ)
Historical Stock Chart
From May 2024 to Jun 2024
Nordion Inc. (NYSE:NDZ)
Historical Stock Chart
From Jun 2023 to Jun 2024